Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Gentamicin
Drug ID BADD_D01016
Description Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from _Micromonospora purpurea_ in 1963.[A234349] It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability.[A234339,A234354] Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment of severe gram-negative infections including those caused by _Pseudomonas aeruginosa_.[A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.[A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects.[A234359,A234364] Although gentamicin is well-established and may be used in a variety of clinical applications, it is also associated with severe adverse effects including nephrotoxicity and ototoxicity which may limit its use.[A234369]
Indications and Usage Not Available
Marketing Status approved; vet_approved
ATC Code D06AX07; J01GB03; S01AA11; S02AA14; S03AA06
DrugBank ID DB00798
KEGG ID D08013
MeSH ID D005839
PubChem ID 3467
TTD Drug ID D0L9UU
NDC Product Code 63323-173; 0143-9128; 0143-9129; 51662-1508
UNII T6Z9V48IKG
Synonyms Gentamicins | Gentamycins | Garamycin | Gentacycol | Gentamicin Sulfate | Sulfate, Gentamicin | Gentamicin Sulfate (USP) | Gentavet | Genticin | G-Myticin | G Myticin | GMyticin | Gentamicin | Gentamycin
Chemical Information
Molecular Formula C21H43N5O7
CAS Registry Number 1403-66-3
SMILES CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Headache17.14.01.001--
Hepatomegaly09.01.05.001---
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypervolaemia02.05.04.019; 14.05.06.003---
Hypoaesthesia17.02.06.023; 23.03.03.081---
Hypocalcaemia14.04.01.004--
Hypokalaemia14.05.03.002--
Hypomagnesaemia14.04.02.001--
Hypotension24.06.03.002--
Injection site pain08.02.03.010; 12.07.03.011---
Instillation site pain08.02.01.008; 12.07.01.008---
Laryngeal oedema10.01.05.003; 22.04.02.001; 23.04.01.005--
Lethargy08.01.01.008; 17.02.04.003; 19.04.04.004--
Leukopenia01.02.02.001---
Muscle twitching15.05.03.005---
Muscular weakness15.05.06.001; 17.05.03.005--
Myasthenic syndrome10.04.05.005; 15.05.08.003; 16.32.01.002; 17.05.04.004---
Nausea07.01.07.001--
Nephropathy toxic12.03.01.010; 20.05.03.002---
Neuropathy peripheral17.09.03.003---
Neurotoxicity12.03.01.011; 17.02.10.002---
Oliguria20.01.03.004---
Pain08.01.08.004--
Paraesthesia17.02.06.005; 23.03.03.094--
Phlebitis12.02.01.002; 24.12.03.004--
Pruritus23.03.12.001--
Pulmonary fibrosis22.01.02.006--
Purpura01.01.04.003; 23.06.01.004; 24.07.06.005--
Pyrexia08.05.02.003--
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene